Does KYNAMRO Cause Injection site discolouration? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site discolouration have been filed in association with KYNAMRO. This represents 10.0% of all adverse event reports for KYNAMRO.
5
Reports of Injection site discolouration with KYNAMRO
10.0%
of all KYNAMRO reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site discolouration From KYNAMRO?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KYNAMRO. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does KYNAMRO Cause?
Injection site erythema (12)
Drug dose omission (11)
Influenza like illness (9)
Injection site pain (9)
Injection site pruritus (8)
Hepatic enzyme increased (7)
Liver function test abnormal (5)
Pain (5)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)